- Why We Need Biomarkers: Lessons from HIV Drug Development
FDA Critical Path Initiative Workshop on Biomarkers • Bethesda, MD, USA • 15 September 2008 • Mark Harrington
- ADAP coverage chart by state of HCV treatments & supportive therapies
Hepatitis A (HAV) & Hepatitis B (HBV) vaccines, Hepatitis C treatment, growth factors, & selective serotonin reuptake inhibitors (SSRIs) (updated 9/11/2008)
- Tuberculosis Research & Development: A Critical Analysis of Funding Trends, 2005-2006
 Revision July 2008
- TB/HIV Advocacy Project brochure • August 2008
Battling the Dual Epidemic through Community Action
- Moving from Universal Access to Comprehensive and Universal Primary Health Care for All • powerpoint
 • word
special session • Mark Harrington •
XVII International AIDS Conference, Mexico City, Mexico, 6 August 2008
- 2008 Pipeline Report • Press Release
HIV, Tuberculoses, Hepatitis B, Hepatitis C: drugs, diagnostics, vaccines and microbicides in development.
- Guide to Hepatitis C for People Living With HIV
Order copies of Guide
|
![[ search ]](images/searchx.gif){kind=small}
![[ subscribe ]](images/subscribe.gif){kind=small}
![[ contact ]](images/contactx.gif){kind=small}